1st Quarter - Termination Amendment
W STRATEGIES, LLC for ACTELION PHARMACEUTICALS US, INC
Firm
Income
$20,000
Expenses
—
Terminated
Mar 1, 2018
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report | Apr 19, 2018 | $30,000 | Replaced |
| 1st Quarter - Termination | Apr 19, 2018 | $30,000 | Replaced |
| 1st Quarter - Termination Amendment (this page) | Apr 25, 2018 | $20,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Education about the importance of access to innovative drug therapies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.